Intellectual property

The company’s technology is protected by patents in order to provide a strong IP protection, one of the Company’s most important assets. Its technology, applications and products, both in the medical and nonmedical fields, are protected by the laws of the United States and other jurisdictions worldwide. The Company’s measurement technology utilizes a technique that measures a range of physical parameters as a function of time to a level of accuracy previously unattainable.

Our patents

METHODS AND SYSTEMS FOR ESTIMATION OF OBSTRUCTIVE SLEEP APNEA SEVERITY IN WAKE SUBJECTS BY MULTIPLE SPEECH ANALYSES

Patent number US 11,672,472 B2. Date of patent Ju. 13, 2023

DETERMINING APNEA-HYPOPNIA INDEX AHI FROM SPEECH

Patent number US 020150351663A1

​HIGH-SENSITIVITY SENSORS FOR SENSING VARIOUS PHYSIOLOGICAL PHENOMENA, PARTICULARLYUSEFUL IN ANTI-SNORING APPARATUS AND METHODS

Patent number US 7,866,212 B2, issued on January 11, 2011.

APPARATUS FOR USE IN CONTROLLING SNORING AND SENSOR UNIT PARTICULARLY USEFUL THEREN

Patent number US 7,716,988 B2, issued on May 18, 2010.

APPARATUS AND METHOD FOR DIAGNOSING SLEEP QUALITY

Patent number US 11,633,150 B2. Date of patent Apr. 25, 2023.

ESTIMATION OF SLEEPQUALITY PARAMETERS FROM WHOLE NIGHT AUDIO ANALYSIS

Patent number US 2020/1193423 A1, issued on March 26, 2020.

APPARATUS AND METHOD FOR DIAGNOSING OBSTRUCTIVE SLEEP APNEA:

- USA patent number – US 9,844,336 B2, issued on December 19, 2017.
- European patent number – EP2608717 A4, issued on May 11, 2016.
- Israeli patent number – IL224852A.
The company’s technology is protected by patents

With distinctive innovative sensor technologies and algorithms, the Company is well-positioned to become a market leader in the snoring and obstructive sleep apnea treatment markets.